© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
CAPSTONE HEALTH SERVICES FOUNDATION PC
850 5TH AVE E
March 01, 2021
Injectables are driving the growth because they can be taken less frequently and adherence is a problem with oral medications.
February 24, 2021
The FDA approved the use of Entresto in a broader group of heart failure patients that includes a large percentage of those with preserved ejection fraction.
February 22, 2021
Application to the FDA is based on results from a placebo-controlled trial showing a 15% decrease in body weight among those who are obese or overweight.
February 16, 2021